{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:47:45Z","timestamp":1783648065725,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.beem.2023.101825","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:10:38Z","timestamp":1695877838000},"page":"101825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of long-acting growth hormone replacement therapy in adult growth hormone deficiency: Comparison between adolescent, adult, and elderly patients"],"prefix":"10.1016","volume":"37","author":[{"given":"Atil Y.","family":"Kargi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.beem.2023.101825_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrendo.2013.77","article-title":"Diagnosis and treatment of growth hormone deficiency in adults","volume":"9","author":"Kargi","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"26","key":"10.1016\/j.beem.2023.101825_bib2","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1056\/NEJMra1817346","article-title":"Pathogenesis and diagnosis of growth hormone deficiency in adults","volume":"380","author":"Melmed","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2023.101825_bib3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.20945\/2359-3997000000189","article-title":"Personalized approach to growth hormone replacement in adults","volume":"63","author":"van Bunderen","year":"2019","journal-title":"Arch Endocrinol Metab"},{"issue":"64","key":"10.1016\/j.beem.2023.101825_bib4","article-title":"Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacement","volume":"4","author":"Reed","year":"2013","journal-title":"Front Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2023.101825_bib5","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4158\/GL-2019-0405","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of Growth Hormone Deficiency in adults and in patients transitioning from pediatric to adult care","volume":"25","author":"Yuen KCJ","year":"2019","journal-title":"Endocr Pr"},{"issue":"1","key":"10.1016\/j.beem.2023.101825_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11154-020-09605-1","article-title":"Individual sensitivity to growth hormone replacement in adults","volume":"22","author":"Boguszewski","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"10.1016\/j.beem.2023.101825_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ecl.2006.11.002","volume":"36","author":"Attanasio","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"10.1016\/j.beem.2023.101825_bib8","first-page":"82","article-title":"Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group","volume":"82","author":"Attanasio","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2023.101825_bib9","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1210\/jcem.86.10.7896","article-title":"Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study","volume":"86","author":"Koranyi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2023.101825_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1530\/EJE-09-0973","article-title":"Models to predict changes in serum IGF1 and body composition in response to GH replacement therapy in GH deficient adults","volume":"162","author":"Barbosa","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2023.101825_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2265.2000.01104.x","article-title":"Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database","volume":"53","author":"Monson","year":"2000","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101825_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4158\/EP.14.2.143","article-title":"Compliance and persistence in pediatric and adult patients receiving growth hormone therapy","volume":"14","author":"Rosenfeld","year":"2008","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.beem.2023.101825_bib13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/cen.13030","article-title":"Is insulin-like growth factor-I a good marker for treatment adherence in growth hormone deficiency in adulthood?","volume":"84","author":"Auer","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2023.101825_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11102-020-01046-y","article-title":"Motivation for and adherence to growth hormone replacement therapy in adults with hypopituitarism: the patients' perspective","volume":"23","author":"Kreitschmann-Andermahr","year":"2020","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.beem.2023.101825_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1055\/a-0956-1919","volume":"129","author":"Amereller","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"10.1016\/j.beem.2023.101825_bib16","doi-asserted-by":"crossref","first-page":"e2121","DOI":"10.1210\/clinem\/dgz149","article-title":"Long-acting growth hormone preparations \u2013 current status and future considerations","volume":"105","author":"Miller","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101825_bib17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.20945\/2359-3997000000190","article-title":"Perspectives on long-acting growth hormone therapy in children and adults","volume":"63","author":"Lal","year":"2019","journal-title":"Arch Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2023.101825_bib18","article-title":"Usefulness and potential pitfalls of long-acting growth hormone analogs","volume":"24","author":"Yuen","year":"2021","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101825_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102421","article-title":"Efficacy and safety of long-acting growth hormone in adult growth hormone deficiency: a systematic review and meta-analysis","volume":"16","author":"Dutta","year":"2022","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.beem.2023.101825_bib20","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/199913a0","article-title":"A metabolic regulating device based on the actions of human growth hormone and of insulin, singly and together, on the human forearm","volume":"199","author":"Rabinowitz","year":"1963","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.beem.2023.101825_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ajhb.1310050603","article-title":"Evaluation of pulsatile patterns of growth hormone release in humans: a brief review MARK L","volume":"5","author":"Hartman","year":"1993","journal-title":"Am J Hum Biol"},{"issue":"5","key":"10.1016\/j.beem.2023.101825_bib22","doi-asserted-by":"crossref","first-page":"E1008","DOI":"10.1152\/ajpendo.00513.2001","article-title":"Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans","volume":"283","author":"Jaffe","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101825_bib23","article-title":"Growth hormone in aging","author":"Garcia","year":"2019","journal-title":"Endotext"},{"issue":"3","key":"10.1016\/j.beem.2023.101825_bib24","first-page":"1222","article-title":"Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults","volume":"86","author":"Laursen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101825_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1040046","article-title":"Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation","author":"Bidlingmaier","year":"2022","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101825_bib26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1210\/clinem\/dgaa775","article-title":"Optimal monitoring of weekly IGF-I levels during growth hormone therapy with once-weekly somapacitan","volume":"106","author":"Juul Kildemoes","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2023.101825_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-17-1073","article-title":"Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial","volume":"178","author":"Johannsson","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2023.101825_bib28","doi-asserted-by":"crossref","first-page":"e1358","DOI":"10.1210\/clinem\/dgaa049","article-title":"Once-weekly Somapacitan is effective and well tolerated in qdults with GH deficiency: a randomized phase 3 trial","volume":"105","author":"Johannsson","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2023.101825_bib29","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/cen.14273","article-title":"Similar safety and efficacy in previously treated adults with growth hormone deficiency randomized to once\u2010weekly somapacitan or daily growth hormone","volume":"93","author":"Otsuka","year":"2020","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2023.101825_bib30","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1210\/jc.2010-2819","article-title":"Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency","volume":"96","author":"Biller","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101825_bib31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11102-012-0422-8","article-title":"12-Month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency","volume":"16","author":"Biller","year":"2013","journal-title":"Pituitary"},{"issue":"12","key":"10.1016\/j.beem.2023.101825_bib32","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1210\/jc.2005-0928","article-title":"Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency","volume":"90","author":"Hoffman","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2023.101825_bib33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/EJE-16-0748","article-title":"MOD-4023, a long-acting carboxy-terminal peptide (CTP)-modified human 3 growth hormone: results of a Phase 2 study in growth hormone-deficient adults","volume":"176","author":"Strasburger","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2023.101825_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/EC-17-0007","article-title":"A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency","volume":"6","author":"H\u00f6ybye","year":"2017","journal-title":"Endocr Connect"},{"issue":"5","key":"10.1016\/j.beem.2023.101825_bib35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ghir.2007.04.010","article-title":"Growth hormone replacement throughout life: insights into age-related responses to treatment","volume":"17","author":"Clayton","year":"2007","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"10.1016\/j.beem.2023.101825_bib36","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1210\/jc.2003-030685","article-title":"Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly","volume":"89","author":"Murray","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101825_bib37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1530\/EJE-07-0016","article-title":"Heterogeneity in responsiveness of perceived quality of life to body composition changes between adult- and childhood-onset Japanese hypopituitary adults with GH deficiency during GH replacement","volume":"156","author":"Urushihara","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.beem.2023.101825_bib38","article-title":"GH replacement in the elderly: Is it worth it?","volume":"15","author":"Ricci Bitti","year":"2021","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2023.101825_bib39","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EC-16-0024","article-title":"Growth hormone deficiency during young adulthood and the benefits of growth hormone replacement","volume":"5","author":"Ahmid","year":"2016","journal-title":"Endocr Connect"},{"issue":"5","key":"10.1016\/j.beem.2023.101825_bib40","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1210\/jcem.85.5.6598","article-title":"Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study","volume":"85","author":"Vahl","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2023.101825_bib41","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1210\/jc.2004-1844","article-title":"Common carotid intima-media thickness in growth hormone (GH)-deficient adolescents: a prospective study after GH withdrawal and restarting GH replacement","volume":"90","author":"Colao","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2023.101825_bib42","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1210\/jcem.87.8.8777","article-title":"The cardiovascular risk of GH-deficient adolescents","volume":"87","author":"Colao","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2023.101825_bib43","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1210\/jc.2005-0208","article-title":"Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial","volume":"90","author":"Mauras","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101825_bib44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1054\/ghir.2000.0175","article-title":"Safety issues in children and adolescents during growth hormone therapy \u2013 a review","volume":"10","author":"Clayton","year":"2000","journal-title":"Growth Horm IGF Res"},{"issue":"2","key":"10.1016\/j.beem.2023.101825_bib45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/eje.1.01829","article-title":"Consensus statement on the management of the GH-treated adolescent in the transition to adult care","volume":"152","author":"Clayton","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2023.101825_bib46","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2023.101825_bib47","doi-asserted-by":"crossref","first-page":"451","DOI":"10.23736\/S0391-1977.18.02834-1","article-title":"Growth hormone deficiency and pregnancy: any role for substitution?","volume":"43","author":"Vila","year":"2018","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.beem.2023.101825_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1040503","article-title":"Growth hormone in fertility and infertility: mechanisms of action and clinical applications","volume":"13","author":"Chang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.beem.2023.101825_bib49","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1365-2265.2011.04137.x","article-title":"Effects of growth hormone replacement within the KIMS survey on estimated cardiovascular risk and predictors of risk reduction in patients with growth hormone deficiency","volume":"75","author":"Schneider","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.beem.2023.101825_bib50","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0267","article-title":"Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies","volume":"12","author":"H\u00f6ybye","year":"2022","journal-title":"Endocr Connect"},{"issue":"11","key":"10.1016\/j.beem.2023.101825_bib51","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1210\/jcem.86.11.7997","article-title":"Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency","volume":"86","author":"Hernberg-St\u00e5hl","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2023.101825_bib52","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1210\/jc.2004-1114","article-title":"Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients","volume":"89","author":"Giavoli","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2023.101825_bib53","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1089\/thy.2008.0266","article-title":"Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency","volume":"18","author":"Losa","year":"2008","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.beem.2023.101825_bib54","doi-asserted-by":"crossref","first-page":"B117","DOI":"10.1093\/gerona\/53A.2.B117","article-title":"Growth hormone in postmenopausal women after long-term oral estrogen replacement therapy","volume":"53","author":"Moe","year":"1998","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"10.1016\/j.beem.2023.101825_bib55","doi-asserted-by":"crossref","first-page":"bvad054","DOI":"10.1210\/jendso\/bvad054","article-title":"Long-term effectiveness and safety of GH replacement therapy in adults > 60 years: data from Nordinet IOS and ANSWER","volume":"7","author":"Biller","year":"2023","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.beem.2023.101825_bib56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11154-020-09599-w","article-title":"Growth hormone deficiency and replacement therapy in adults: impact on survival","volume":"22","author":"Van Bunderen","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"10.1016\/j.beem.2023.101825_bib57","doi-asserted-by":"crossref","first-page":"P35","DOI":"10.1530\/EJE-21-1186","article-title":"Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement","volume":"186","author":"Boguszewski","year":"2022","journal-title":"Eur J Endocrinol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:00:18Z","timestamp":1761498018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X23000994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1521690X23000994"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2023.101825","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of long-acting growth hormone replacement therapy in adult growth hormone deficiency: Comparison between adolescent, adult, and elderly patients","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2023.101825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101825"}}